View |
|
DR-XY45284
|
Tropisetron (As Hydrochloride)
|
Setrovel
|
1 mg/mL (5 mg/5mL)
|
Solution for I.V. Injection
|
-
|
PT. Novell Pharmaceutical Laboratories
|
Indonesia
|
-
|
11 March 2022
|
11 April 2026
|
View |
|
DRP-10275-05
|
Febuxostat
|
Fixuric 40
|
40 mg
|
Film-Coated Tablet
|
-
|
Titan Laboratories Pvt. Ltd.
|
India
|
-
|
16 March 2022
|
06 September 2026
|
View |
|
DRP-10276-03
|
Febuxostat
|
Fixuric 80
|
80 mg
|
Film-Coated Tablet
|
-
|
Titan Laboratories Pvt. Ltd.
|
India
|
-
|
16 March 2022
|
06 September 2026
|
View |
|
DRP-11492
|
Omeprazole (as sodium)
|
Blomes
|
40 mg
|
Lyophilized Powder For Injection (IV Infusion)
|
-
|
Jodas Expoim Pvt. Ltd.
|
India
|
-
|
17 March 2022
|
17 March 2027
|
View |
|
DRP-11487
|
Paracetamol + Tramadol HCi
|
None
|
325mg/37.5mg
|
Film-Coated Tablet
|
-
|
Fredun Pharmaceuticals Limited
|
India
|
-
|
16 March 2022
|
16 March 2027
|
View |
|
HRP-069-03
|
Carbocisteine
|
Plemalis
|
50 mg / mL
|
Suspension (Oral Drops)
|
MUCOLYTIC
|
J.M. Tolmann Laboratories, Inc.
|
Philippines
|
Automatic Renewal
|
26 July 2023
|
09 August 2028
|
View |
|
DRP-8961-01
|
Carboplatin
|
Carbo-Health 150
|
10mg mL (150mg / 15mL)
|
Solution For Injection
|
Antineoplastic (Platinum Compound)
|
Admac Lifesciences
|
India
|
Automatic Renewal
|
13 April 2023
|
29 July 2028
|
View |
|
DRP-11495
|
Paclitaxel
|
Paxol
|
6 mg/mL (260 mg/ 43.4 mL)
|
Concentrate Solution for
Injection (IV Infusion)
|
-
|
Venus Remedies, Limited
|
India
|
Initial
|
13 July 2022
|
17 March 2027
|
View |
|
DRP-11494
|
Paclitaxel
|
Paxol
|
6 mg/mL (300 mg/50 mL)
|
Concentrate Solution for
Injection (IV Infusion)
|
-
|
Venus Remedies, Limited
|
India
|
-
|
17 March 2022
|
17 March 2027
|
View |
|
DR-XY37705
|
Calcium + Cholecalciferol (Vitamin D3) + Minerals
|
Caltrate Plus
|
Formulation: Each film-coated tablet contains: Calcium (equivalent as Calcium Carbonate 1.499 g Cholecalciferol (Vitamin D3) Copper (equivalent as Cupric Oxide 1.25mg) Magnesium (equivalent as Magnesium Oxide 82.89 mg) Manganese (equivalent as Manganese Sulfate Monohydrate 5.54 mg) Zinc (equivalent as Zinc Oxide 9.34mg)
600 mg 200 IU
1 mg 50 mg 1.8 mg 7.5 mg
|
Film-Coated Tablet
|
-
|
Wyeth Pharmaceutical Company, Ltd.
|
China
|
-
|
11 March 2022
|
29 March 2025
|
View |
|
DR-XY47823
|
Paclitaxel
|
Paxus 30
|
6 mg/mL (30 mg/5 mL)
|
Solution for Injection
(IV Infusion)
|
Antineoplastic Agent (Taxane)
|
PT Global Onkolab Farma
|
Indonesia
|
Initial
|
17 March 2022
|
17 March 2027
|
View |
|
DRP-9885-04
|
Ascobic Acid + Zinc
|
Ceetrene
|
500 mg (equivalent to 562.43 mg Sodium Ascorbate)/ 10 mg (equivalent to 70 mg Zinc Gluconate)
|
Capsule
|
-
|
J.M. Tolmann Laboratories, Inc.
|
Philippines
|
Initial
|
17 January 2023
|
25 January 2026
|
View |
|
DRP-11490
|
Potassium Chloride
|
Kaliusaphride- Inf
|
2 mEq/mL
|
Solution for Injection (IV Infusion)
|
-
|
Kilitch Drugs (India) Ltd.
|
India
|
-
|
17 March 2022
|
17 March 2027
|
View |
|
DRP-11488
|
Gliclazide
|
Saphclazide 30
|
30 mg
|
Modified Release Tablet
|
-
|
Sapphire Lifesciences Pvt. Ltd.
|
India
|
-
|
17 March 2022
|
17 March 2027
|
View |
|
DRP-4717-08
|
Dobutamine Hydrochloride
|
Dopacent
|
40 mg /mL (200 mg / 5 mL )
|
Solution For Injection (IV Infusion)
|
Adrenergic Agent
|
Myungmoon Pharmaceutical Co., Ltd.
|
Korea
|
Automatic Renewal
|
12 July 2023
|
17 September 2028
|
View |
|
DRP-3054
|
Losartan Potassium + Hydrocholorothiazide
|
Punsartan
|
50 mg/12.5 mg
|
Film-Coated Tablet
|
-
|
Saga Laboratories
|
India
|
Renewal
|
11 March 2022
|
04 April 2026
|
View |
DRP-8719-03_PI_01.pdf
|
DRP-8719-03
|
Aciclovir
|
Aciclospeed
|
50mg/g
|
Cream
|
-
|
Interphil Laboratories, Inc.
|
Philippines
|
-
|
16 March 2022
|
14 September 2025
|
View |
DRP-4870-03_PI_01.pdf
|
DRP-4870-03
|
Betamethasone + Dexchlorpheniramine Maleate
|
Allerspeed
|
250mcg/2mg
|
Tablet
|
Corticosteroid/Antihistamine
|
Interphil Laboratories, Inc.
|
Philippines
|
Renewal
|
15 August 2023
|
07 November 2028
|
View |
|
DRP-1455-07
|
Clindamycin (as hydrochloride)
|
Clindaspeed
|
300mg
|
Capsule
|
Antibacterial (Lincosamide)
|
Interphil Laboratories, Inc.
|
Philippines
|
Renewal
|
18 August 2023
|
04 December 2028
|
View |
|
DRP-11444
|
Hydroquinone
|
Dr. AlvinĀ® Rejuvenating Plain Advance
|
40 mg per g (4% w/w)
|
Topical Lotion
|
Depigmenting Agent
|
Carmel Laboratories Inc.
|
Philippines
|
Initial [OTC][PCPR]
|
28 April 2022
|
14 March 2027
|